Skip to main content
OpenTrials
Completed

NCT Number: NCT07276113

Enriched Eggs as a Sustainable Approach to Enhance Omega-3 Status in Elite Athletes

The study looked to identify the benefit of omega-3 enriched eggs on circulating omega-3 fatty acid profile of elite level athletes

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Sport Ireland Institute, Dublin, Ireland

Loading trial locations.

About this study

Study hypothesis: Consuming omega-3 enriched eggs (compared to control) will (1) increase omega-3 index whilst also (2) improving subjective markers of recovery and other health parameters.

Aims & objective:

Overall aim: To investigate the impact of consuming omega-3 enriched eggs blood fatty acid profile among elite level athletes who do not reach omega-3 index targets of 8%, compared to control. Secondary data collected will analyse the impact on health and recovery parameters.

Primary objective: To assess the effect of consuming omega-3 enriched eggs on blood fatty acid response (omega-3 index) in elite level athletes.

Secondary objective: To assess the effect of consuming omega-3 enriched eggs on subjective recovery markers using validated questionnaires (RESTQ-Sport-36, appendix 1; Acute Recovery & Stress Scale, appendix 2) and other health parameters including resting heart rate and blood pressure.

Recruitment Participants will be recruited from Sport Ireland Institute of Sport (SII). SII are partners for this PhD and will provide access for recruitment to those teams/ athletes based in Dublin. Further recruitment will be open to teams across the island of Ireland where potential participants are competing at the highest level within that sport. All relevant permissions will be obtained before commencing any recruitment strategy. All recruitment will initially require approval from the Head of Performance for that sport, this will allow for the researcher to provide athletes with an information sheet, screening questionnaire and consent form. Secondary recruitment will be via a poster which will be put up around the campus. This recruitment will be provided approval by relevant individuals in SII and QUB. The poster will have a QR code which links the interested party to the participant information sheet and screening questionnaire.

Primary objective data collection:

Participants from both omega-3 enriched group and control group will provide a dried blood spot at week 0 (before starting intervention) and post 8-week intervention. The first step is to increase blood flow to the hands; this is done by asking the participant to wash their hands in warm water. The tip of the index finger is prepared with an antibacterial wipe, and this is allowed to dry unassisted. A lancet is then used to draw blood with the first show of blood being wiped away with gauze. The finger is gently squeezed, allowing a blood drop to form. The blood drop is allowed to drop onto the designated spot of the collection card. The collection cards are pre-treated with a proprietary antioxidant treatment called OxyStop, this prevents oxidative loss of PUFAs. The sample is allowed to dry for a few minutes before being sent the same day to a commercial laboratory for analysis (OmegaQuant, University of Stirling, GB).

Co-investigators are familiar with collecting OmegaQuant blood samples through previous professional experience.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Participants must be elite level female athletes (tier 4 or 5)

Exclusion criteria

  • Non-smokers
  • Must not be taking statins to lower LDL cholesterol levels.
  • Must not have high blood pressure (systolic >140/ diastolic >90mmHg)
  • Participants must remain injury free (not miss training >1week)
  • Baseline omega-3 index of <8%
  • Currently include eggs as part of their habitual diet.
  • Participants must be willing to consume 14 eggs per week for 8 weeks.

Treatment and study plan

omega-3 enriched eggs

Other

omega-3 enriched eggs

non-enriched eggs

Other

non-omega-3 enriched eggs

Primary outcomes

  1. omega-3 index

    Time frame: 8 weeks

Sponsors and collaborators

Lead sponsor

Queen's University, Belfast

Other

Registry information

Important dates

Study start
2023
Primary completion
2024
Study completion
2024
First posted
Dec 10, 2025
Registry last updated
Dec 10, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.